These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23109237)

  • 1. Benfluorex-induced cardiac valve injury.
    Acar J
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1243-4; author reply 1245-6. PubMed ID: 23109237
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France.
    Deltour N; Coste M; Tupinon-Mathieu I
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):584-5; author reply 586-8. PubMed ID: 22517617
    [No Abstract]   [Full Text] [Related]  

  • 3. Benfluorex: left heart valve disease very common.
    Prescrire Int; 2014 May; 23(149):128. PubMed ID: 24926516
    [No Abstract]   [Full Text] [Related]  

  • 4. Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus.
    Weill A; Païta M; Tuppin P; Fagot JP; Neumann A; Simon D; Ricordeau P; Montastruc JL; Allemand H
    Pharmacoepidemiol Drug Saf; 2010 Dec; 19(12):1256-62. PubMed ID: 20945504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France.
    Fournier A; Zureik M
    Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):343-51. PubMed ID: 22318872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benfluorex: increasing reports of valve disorders.
    Prescrire Int; 2010 Feb; 19(105):17. PubMed ID: 20455335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benfluorex and cardiac valve disease: long delay in publication.
    Prescrire Int; 2013 Feb; 22(135):47. PubMed ID: 23444509
    [No Abstract]   [Full Text] [Related]  

  • 8. [Valvular heart disease associated with benfluorex].
    Rafel Ribera J; Casañas Muñoz R; Anguera Ferrando N; Batalla Sahún N; Castro Cels A; Pujadas Capmany R
    Rev Esp Cardiol; 2003 Feb; 56(2):215-6. PubMed ID: 12605770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benfluorex: negative data in France, but still on the market. Neuropsychiatric disorders, pulmonary hypertension and heart valve damage.
    Prescrire Int; 2009 Jun; 18(101):124. PubMed ID: 19637435
    [No Abstract]   [Full Text] [Related]  

  • 10. Benfluorex: how many deaths?
    Prescrire Int; 2011 Feb; 20(113):45. PubMed ID: 21488593
    [No Abstract]   [Full Text] [Related]  

  • 11. Valvular heart disease associated with benfluorex.
    Gueffet JP; Piriou N; Trochu JN
    Arch Cardiovasc Dis; 2010 May; 103(5):342-3. PubMed ID: 20619246
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcifications in benfluorex-induced valve heart disease: a misknown association.
    Plurien F; Bruneval P; Jobic Y; Iung B; Ennezat PV
    Cardiology; 2015; 130(2):87-90. PubMed ID: 25614032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benfluorex: the last chapter of drug-induced valvular heart disease?
    Droogmans S; Cosyns B; Van Camp G
    Eur J Echocardiogr; 2011 Apr; 12(4):263-4. PubMed ID: 21193483
    [No Abstract]   [Full Text] [Related]  

  • 14. Mitral and aortic valvular disease associated with benfluorex use.
    Etienne Y; Jobic Y; Frachon I; Fatemi M; Castellant P; Quintin-Roué I
    J Heart Valve Dis; 2011 May; 20(3):348-50. PubMed ID: 21714428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenfluramine-like cardiovascular side-effects of benfluorex.
    Boutet K; Frachon I; Jobic Y; Gut-Gobert C; Leroyer C; Carlhant-Kowalski D; Sitbon O; Simonneau G; Humbert M
    Eur Respir J; 2009 Mar; 33(3):684-8. PubMed ID: 19251806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvular heart disease.
    Boudes A; Lavoute C; Avierinos JF; Le Dolley Y; Villacampa C; Salem A; Loundou AD; Michel N; Renard S; Habib G
    Eur J Echocardiogr; 2011 Sep; 12(9):688-95. PubMed ID: 21810827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying drug-related disorders: a probabilistic approach.
    Prescrire Int; 2013 Dec; 22(144):293. PubMed ID: 24600730
    [No Abstract]   [Full Text] [Related]  

  • 18. Fatal postoperative systemic pulmonary hypertension in benfluorex-induced valvular heart disease surgery: A case report.
    Baufreton C; Bruneval P; Rousselet MC; Ennezat PV; Fouquet O; Giraud R; Banfi C
    Medicine (Baltimore); 2017 Jan; 96(2):e4985. PubMed ID: 28079786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food and Drug Administration criteria for the diagnosis of drug-induced valvular heart disease in patients previously exposed to benfluorex: a prospective multicentre study.
    Maréchaux S; Rusinaru D; Jobic Y; Ederhy S; Donal E; Réant P; Arnalsteen E; Boulanger J; Garban T; Ennezat PV; Jeu A; Szymanski C; Tribouilloy C
    Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):158-65. PubMed ID: 25368209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valvular heart disease associated with benfluorex therapy: results from the French multicentre registry.
    Le Ven F; Tribouilloy C; Habib G; Gueffet JP; Maréchaux S; Eicher JC; Blanchard-Lemoine B; Rousseau J; Hénon P; Jobic Y; Etienne Y
    Eur J Echocardiogr; 2011 Apr; 12(4):265-71. PubMed ID: 21193484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.